Prostaglandin E2 receptors EP2 and EP4 are down-regulated in human mononuclear cells after injury

V E Strong1, J Winter, Z Yan

  • 1Department of Surgery, New York Presbyterian Hospital-Weill Medical College of Cornell Univerity, New York, NY 10021, USA.

Surgery
|August 8, 2001
PubMed
Abstract

Insights

Injury down-regulates prostaglandin E2 (PGE2) receptors EP2 and EP4. Blocking PGE2 production restores receptor expression, suggesting EP receptor targets for immune response augmentation after injury.

Area of Science:

  • Immunology
  • Molecular Biology
  • Prostanoid Signaling

Background:

  • Prostaglandin receptor subtypes are crucial for cellular functions.
  • Distinct signaling pathways of prostanoids may explain their varied effects.
  • Understanding EP receptor modulation post-injury is vital for immune response insights.

Purpose of the Study:

  • To investigate EP2 and EP4 prostaglandin receptor modulation following injury.
  • To assess the impact of prostaglandin E2 (PGE2) addition and blockade on EP receptor expression.

Main Methods:

  • Peripheral blood mononuclear cells (PBMCs) from injured patients and controls were analyzed.
  • PGE2 production, tumor necrosis factor-alpha, and leukotriene B4 were measured.
  • EP receptor and COX-2 mRNA expression were evaluated, alongside PGE2 treatment effects.

Main Results:

  • Injured patients showed increased PGE2 production and COX-2 mRNA, inhibited by NS-398.
  • EP2 and EP4 receptors were significantly down-regulated post-injury.
  • PGE2 addition replicated the down-regulation of EP2 and EP4 receptors.

Conclusions:

  • Specific PGE2 receptors (EP2, EP4) are down-regulated after injury.
  • NS-398 treatment reversed this down-regulation, indicating PGE2's role.
  • EP receptor subtypes represent potential targets for enhancing human immune responses post-injury.

Related Concept Videos

Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own EpiSCs...
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents01:20

Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents

The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Acute Inflammation III: Local and Systemic Effects01:25

Acute Inflammation III: Local and Systemic Effects

Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...